High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer
- 7 April 2006
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 59 (8) , 870-874
Abstract
Background: The prevalence of isolated tumour cells (ITCs) in regional lymph nodes from colorectal cancer (CRC) is controversial and has never been prospectively assessed in large groups of consecutive patients. pN0 early-relapsing CRC can be explained by lymph node-ITC. Aim: : To assess the prevalence of ITCs in regional lymph nodes from 309 consecutive patients with pN0M0 (pathological (p)-tumour-node-metastasis (TNM) staging system) CRCs. Patients and methods: ITCs were assessed by immunohistochemistry (MNF116 monoclonal antibody (1:100); Dako, Glostrup, Denmark) in two serial histological sections obtained from 5016 mesenteric lymph nodes from 309 patients with pN0 CRCs (mean number of lymph nodes per patient = 16.2; p-TNM stage 0, n = 25; p-TNM stage I, n = 123; and p-TNM stage II (A+B), n = 161). Tumour histology, vascular cancer invasion and pathological stage were also recorded. Results: ITCs were detected in the regional lymph nodes of 156 of 309 (50.5%) patients with CRC, mostly in nodes located within 3 cm from the neoplasia. ITC status correlated with (a) tumour p-TNM stage (Pearson’s χ 2 : p2 : p = 0; ordered logistic regression: OR = 4.9; 95% CI = 3.1 to 7.7; pConclusion: More than 50% of pN0-CRC patients have ITCs in the mesenteric lymph nodes. ITC status is significantly correlated with cancer stage and vascular cancer invasion. The clinicopathological effect of ITC remains to be prospectively evaluated.Keywords
This publication has 39 references indexed in Scilit:
- Detection of Lymph Node Micrometastases and Isolated Tumor Cells in Sentinel and Nonsentinel Lymph Nodes of Colon Cancer PatientsWorld Journal of Surgery, 2005
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Adjuvant therapy in colon cancer: current status and future directionsCancer Treatment Reviews, 2002
- Volume of Lymphatic Metastases Does Not Independently Influence Prognosis in Colorectal CancerJournal of Clinical Oncology, 2002
- Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.2002
- Pattern of Lymph Node Micrometastasis and Prognosis of Patients with Colorectal CancerAnnals of Surgical Oncology, 2001
- Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal CancerJournal of Clinical Oncology, 2001
- Lymph node micrometastases do not predict relapse in stage II colon cancerAnnals of Surgical Oncology, 2000
- Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.2000
- International Union Against Cancer. Classification of isolated tumor cells and micrometastasis.1999